Literature DB >> 9923539

Pharmacokinetics of melphalan in isolated limb perfusion.

A Norda1, U Loos, M Sastry, J Goehl, W Hohenberger.   

Abstract

The pharmacokinetics of melphalan was studied by sampling of tissue and plasma in 72 rats that underwent isolated hyperthermic limb perfusion under different conditions. A miniaturized extracorporeal circulation system for small animals was used for perfusion of the rat hindlimb. Melphalan levels (L-phenylalanine mustard, L-PAM) were determined by high-performance liquid chromatography (HPLC). The temperature of the perfusate plasma and tissue, pH, administration method, and flow rate were modified and compared with regard to their influence on pharmacokinetic parameters. The highest tissue penetration of melphalan was observed under the following conditions: (a) pH range of the perfusate plasma between 7.3 and 7.7 (physiological environment), (b) temperature range of the perfusate from 40 degrees to 41.5 degrees C (destruction of cellular carrier systems at higher temperatures and increased inactivation by hydrolysis of melphalan above 41.5 degrees C), (c) application of melphalan as a single dose into the reservoir of the extracorporeal circuit (optimal tissue penetration), and (d) reduced perfusate flow (prolonged contact time between perfusate and tissue).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9923539     DOI: 10.1007/s002800050860

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  3 in total

Review 1.  Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow?

Authors:  T Pencavel; R Seth; A Hayes; A Melcher; H Pandha; R Vile; K J Harrington
Journal:  Gene Ther       Date:  2010-05-06       Impact factor: 5.250

2.  Hyperthermic intraperitoneal chemotherapy with melphalan: a summary of clinical and pharmacological data in 34 patients.

Authors:  Lana Bijelic; Paul H Sugarbaker; O Anthony Stuart
Journal:  Gastroenterol Res Pract       Date:  2012-07-03       Impact factor: 2.260

Review 3.  Management of in-transit melanoma of the extremity with isolated limb perfusion.

Authors:  Douglas L Fraker
Journal:  Curr Treat Options Oncol       Date:  2004-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.